Use of recombinant activated factor VII for acute bleeding episodes in acquired hemophilia: final analysis from the Hemostasis and Thrombosis Research Society Registry acquired hemophilia study

The Hemostasis and Thrombosis Research Society Registry was used to monitor the postapproval use and safety of recombinant activated factor VII (rFVIIa). The objective of this article is to evaluate the data from the Hemostasis and Thrombosis Research Society Registry related to rFVIIa-treated bleed...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Alice D., Kessler, Craig M., Al-Mondhiry, Hamid A.B., Gut, Robert Z., Cooper, David L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams And Wilkins 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5054952/
https://www.ncbi.nlm.nih.gov/pubmed/26761583
http://dx.doi.org/10.1097/MBC.0000000000000471

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5054952/
https://www.ncbi.nlm.nih.gov/pubmed/26761583
http://dx.doi.org/10.1097/MBC.0000000000000471

Ejemplares similares